VIGR – a novel inducible adhesion family G‐protein coupled receptor in endothelial cells
暂无分享,去创建一个
[1] John Q. Davies,et al. The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans. , 2003, Blood.
[2] S. Gordon,et al. Proteolytic cleavage of the EMR2 receptor requires both the extracellular stalk and the GPS motif , 2003, FEBS letters.
[3] Philippe Marin,et al. The ‘magic tail’ of G protein‐coupled receptors: an anchorage for functional protein networks , 2003, FEBS letters.
[4] K. Mann,et al. What is all that thrombin for? , 2003, Journal of thrombosis and haemostasis : JTH.
[5] C. Esmon. Inflammation and thrombosis , 2003, Journal of thrombosis and haemostasis : JTH.
[6] A. Whitehead,et al. ELAM-1/E-selectin promoter contains an inducible AP-1/CREB site and is not NF-κB-specific , 2003 .
[7] H. Schiöth,et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.
[8] David E. Gloriam,et al. There exist at least 30 human G-protein-coupled receptors with long Ser/Thr-rich N-termini. , 2003, Biochemical and biophysical research communications.
[9] O. Stenina. Regulation of gene expression in vascular cells by coagulation proteins. , 2003, Current drug targets.
[10] R. Heller,et al. HE6, a two‐subunit heptahelical receptor associated with apical membranes of efferent and epididymal duct epithelia , 2003, Molecular reproduction and development.
[11] C. Esmon,et al. Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis , 2002, Critical care.
[12] Yun Lu,et al. Post-translational Proteolytic Processing of the Calcium-independent Receptor of α-Latrotoxin (CIRL), a Natural Chimera of the Cell Adhesion Protein and the G Protein-coupled Receptor , 2002, The Journal of Biological Chemistry.
[13] C. Garlanda,et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response , 2002, Nature.
[14] L. Stubbs,et al. EMR4, a Novel Epidermal Growth Factor (EGF)-TM7 Molecule Up-regulated in Activated Mouse Macrophages, Binds to a Putative Cellular Ligand on B Lymphoma Cell Line A20* , 2002, The Journal of Biological Chemistry.
[15] T. Fukuzawa,et al. Cleavage of Ig-Hepta at a “SEA” Module and at a Conserved G Protein-coupled Receptor Proteolytic Site* , 2002, The Journal of Biological Chemistry.
[16] T. van der Poll,et al. Endothelium: Interface between coagulation and inflammation , 2002, Critical care medicine.
[17] B. Berk,et al. The role of MAP kinases in endothelial activation , 2002 .
[18] Martin Stacey,et al. Molecular Analysis of the Epidermal Growth Factor-like Short Consensus Repeat Domain-mediated Protein-Protein Interactions , 2001, The Journal of Biological Chemistry.
[19] S. Gordon,et al. Human Epidermal Growth Factor (EGF) Module-containing Mucin-like Hormone Receptor 3 Is a New Member of the EGF-TM7 Family That Recognizes a Ligand on Human Macrophages and Activated Neutrophils* , 2001, The Journal of Biological Chemistry.
[20] M. Gerstein,et al. The current excitement in bioinformatics-analysis of whole-genome expression data: how does it relate to protein structure and function? , 2000, Current opinion in structural biology.
[21] S Gordon,et al. LNB-TM7, a group of seven-transmembrane proteins related to family-B G-protein-coupled receptors. , 2000, Trends in biochemical sciences.
[22] J. Hayflick. A Family of Heptahelical Receptors With Adhesion-Like Domains: A Marriage Between Two Super Families , 2000, Journal of receptor and signal transduction research.
[23] Haino,et al. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay‐accelerating factor (DAF, CD55) , 1999, Immunology.
[24] N. Thielens,et al. The N-terminal CUB-Epidermal Growth Factor Module Pair of Human Complement Protease C1r Binds Ca2+ with High Affinity and Mediates Ca2+-dependent Interaction with C1s* , 1999, The Journal of Biological Chemistry.
[25] Christian Stehlik,et al. Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis , 1998, The Journal of experimental medicine.
[26] R. V. van Lier,et al. Characterization of the CD55 (DAF)‐binding site on the seven‐span transmembrane receptor CD97 , 1998, European journal of immunology.
[27] J. Vilardaga,et al. Mutational analysis of extracellular cysteine residues of rat secretin receptor shows that disulfide bridges are essential for receptor function. , 1997, European journal of biochemistry.
[28] R. Ivell,et al. Cloning of a human epididymis-specific mRNA, HE6, encoding a novel member of the seven transmembrane-domain receptor superfamily. , 1997, DNA and cell biology.
[29] A. Mould,et al. The CUB domains of procollagen C-proteinase enhancer control collagen assembly solely by their effect on procollagen C-proteinase/bone morphogenetic protein-1. , 1997, Matrix biology : journal of the International Society for Matrix Biology.
[30] M J Roth,et al. CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. , 1996, Journal of immunology.
[31] R. V. van Lier,et al. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF) , 1996, The Journal of experimental medicine.
[32] P. Schlag,et al. Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. , 1996, Blood.
[33] F. Bach,et al. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B , 1996, The Journal of experimental medicine.
[34] E. Hartmann,et al. Expression cloning and chromosomal mapping of the leukocyte activation antigen CD97, a new seven-span transmembrane molecule of the secretion receptor superfamily with an unusual extracellular domain. , 1995, Journal of immunology.
[35] T. Maniatis,et al. Transcriptional regulation of endothelial cell adhesion molecules: NF‐κB and cytokine‐inducible enhancers , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] T. Lint,et al. Structure and function of the pentraxins. , 1995, Current opinion in immunology.
[37] B. Dahlbäck,et al. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation. , 1994, Journal of immunology.
[38] A. Whitehead,et al. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. , 1994, Immunology today.
[39] P. Bork,et al. The CUB domain. A widespread module in developmentally regulated proteins. , 1993, Journal of molecular biology.
[40] D. Haake,et al. Identification of Treponema pallidum subspecies pallidum genes encoding signal peptides and membrane‐spanning sequences using a novel alkaline phosphatase expression vector , 1991, Molecular microbiology.
[41] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[42] J. Pober. Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. , 1988, The American journal of pathology.
[43] E. Triphosphat,et al. FEBS Letters , 1987, FEBS Letters.
[44] C. Larsen,et al. Immunogenetics , 2005, Genes and Immunity.
[45] S. Gordon,et al. The EGF-TM7 family: a postgenomic view , 2003, Immunogenetics.
[46] M. Saraste,et al. FEBS Lett , 2000 .
[47] J. Duke-Cohan,et al. Attractin: a cub-family protease involved in T cell-monocyte/macrophage interactions. , 2000, Advances in experimental medicine and biology.
[48] P. Nawroth,et al. LPS and Cytokine-Activated Endothelium , 2000, Seminars in thrombosis and hemostasis.
[49] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.